מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
Potassium chloride; Glucose monohydrate
B. Braun Melsungen AG
B05BB; B05BB02
Potassium chloride; Glucose monohydrate
0.3%w/v + 5.0 percent weight/volume
Solution for infusion
Product subject to prescription which may not be renewed (A)
Solutions affecting the electrolyte balance; electrolytes with carbohydrates
Not marketed
2012-07-27
PACKAGE LEAFLET: INFORMATION FOR THE USER POTASSIUM CHLORIDE 0.3% W/V AND GLUCOSE 5% W/V SOLUTION FOR INFUSION Potassium chloride and glucose READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Potassium Chloride 0.3% w/v and Glucose 5% w/v is and what it is used for 2. What you need to know before you use Potassium Chloride 0.3% w/v and Glucose 5% w/v 3. How to use Potassium Chloride 0.3% w/v and Glucose 5% w/v 4. Possible side effects 5. How to store Potassium Chloride 0.3% w/v and Glucose 5% w/v 6. Contents of the pack and other information 1. WHAT POTASSIUM CHLORIDE 0.3% W/V AND GLUCOSE 5% W/V IS AND WHAT IT IS USED FOR This medicine contains a solution of potassium chloride and glucose. It is administered to you through a tube placed into a vein (intravenous drip). You will receive it to maintain or restore your potassium levels and to cover your basic energy requirements. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE THIS MEDICINE DO NOT USE POTASSIUM CHLORIDE 0.3% W/V AND GLUCOSE 5% W/V • if you have too high levels of potassium or chloride in your blood (hyperkalaemia or hyperchloremia) • if you have severe kidney disease • if you have had a head injury (during the first 24 hours) • if you have too much water in your body (hyperhydration) • if you have too high blood sugar levels (hyperglycaemia) • if you have recently suffered from a stroke WARNINGS AND PRECAUTIONS Patients who are acutely ill, with pain, postoperative stress, infections, burns, nervous system, heart, liver and kidney קרא את המסמך השלם
Health≙Products≙Regulatory≙Authority 31≙January≙2019 CRN008L8F Page≙1≙of≙11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Potassium≙Chloride≙0.3%≙w/v≙and≙Glucose≙5%≙w/v≙Solution≙for≙Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1000≙ml≙of≙solution≙for≙infusion≙contains: Potassium≙chloride≙3.00g Glucose≙(as≙Glucose≙monohydrate)≙50.00g _Electrolyte concentrations:_ Potassium≙40≙mmol/l Chloride≙40≙mmol/l For≙the≙full≙list≙of≙excipients,≙see≙section≙6.1. 3 PHARMACEUTICAL FORM Solution≙for≙infusion Clear,≙colourless≙up≙to≙faintly≙straw-coloured≙aqueous≙solution Energy≙835≙kJ/l≙ ≙≙ 200≙kcal/l Theoretical≙osmolarity≙358≙mOsm/l pH≙3.5≙–≙6.5 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Supply≙of≙potassium≙to≙correct≙or≙prevent≙potassium≙deficiency≙and≙supply≙of≙ glucose≙to≙cover≙basic≙energy≙requirements. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The≙dosage≙is≙dependent≙on≙age,≙weight≙and≙clinical≙condition≙of≙the≙patient,≙ especially≙those≙with≙renal≙or≙cardiac≙insufficiency.≙Fluid≙balance,≙serum≙glucose,≙ serum≙sodium≙and≙other≙electrolytes≙may≙need≙to≙be≙monitored≙before≙and≙during≙ administration,≙especially≙in≙patients≙with≙increased≙non-osmotic≙vasopressin≙release≙ (syndrome≙of≙inappropriate≙antidiuretic≙hormone≙secretion,≙SIADH)≙and≙in≙patients≙ co-medicated≙with≙vasopressin≙agonist≙drugs≙due≙to≙the≙risk≙of≙hyponatraemia. Health≙Products≙Regulatory≙Authority 31≙January≙2019 CRN008L8F Page≙2≙of≙11 Monitoring≙of≙serum≙sodium≙is≙particularly≙important≙for≙physiologically≙hypotonic≙ fluids.≙Potassium≙Chloride≙0.3≙%≙w/v≙and≙Glucose≙5%≙w/v≙Solution≙for≙Infusion≙may≙ become≙hypotonic≙after≙administration≙due≙to≙glucos קרא את המסמך השלם